Colgate Palmolive (COLPAL.NS) traded up 0.65 % during a 24 hours period ending at 02:12 PM Central Europe on Tuesday 27th. One Colgate Palmolive stock can currently be bought for about INR 1,603.4 on popular exchanges. Current supply of Colgate Palmolive stocks is 272 mn. Colgate Palmolive has a current market capitalization of INR 436.5 bn and approximately INR 1.2 bn worth of Colgate Palmolive was traded on exchanges in the last 24 hours. Since last month end, Colgate Palmolive has traded -12.48 % down. Simple moving average of last 200 days is at INR 2,007.96. The highest price of past 52 weeks was recorded at INR 2,301.6 on 02/27/2026. 52 weeks low was at INR 1,580 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Sbi Cards & Payment Services (SBICARD.NS) traded down -3.66 % and now trades at INR 528.05. Sbi Cards & Payment Services has a market capitalisation of INR 519.2 bn. Sbi Cards & Payment Services has a current price to earnings ratio of 23.35. Motilal Oswal has upgraded its earnings outlook for SBI Cards, citing robust profit after tax in the latest quarter and a stable net‑interest margin that is expected to remain broadly unchanged despite rising borrowing costs. The brokerage forecasts a favourable return on assets and equity for FY28, and has raised its target price to a neutral level with a revised fair value estimate. In contrast, other analysts have taken a more cautious view. JPMorgan cut its target price, warning that muted loan growth, potential margin pressure and higher funding costs could constrain profitability, while Kotak Securities retains a bullish stance, pointing to improving credit costs and lower provisions as key earnings drivers. Nuvama reduced its valuation target but noted that rising margin and asset‑quality headwinds may temper upside.
Mphasis (MPHASIS.NS) traded up 3.13 % and now trades at INR 2,618.4. Current market capitalisation for Mphasis is INR 473.4 bn. Mphasis has a current price to earnings ratio of 26.56. MPHASIS LIMITED reported a modest decline in its quarterly performance, with revenue and operating income both showing a moderate increase compared to the previous year. The company’s earnings before tax rose, supported by gains across its core IT service segments, while operating expenses grew in line with the expansion of its workforce and investment in technology. Profit after tax improved, reflecting efficient cost management and a stronger contribution from international services. The company reiterated its focus on scaling its global footprint and enhancing product offerings, while maintaining disciplined capital allocation. Market‑level guidance remains conservative, with emphasis on sustaining margin expansion and continued investment in AI‑driven solutions.
Mrf (MRF.NS) traded down -0.8 % and now trades at INR 118,030. Mrf has a market capitalisation of INR 500.1 bn. Mrf has a current price to earnings ratio of 21.18.
Coromandel (COROMANDEL.NS) traded up 0.73 % and now trades at INR 1,738.4. Coromandel has a market capitalisation of INR 506.1 bn. Coromandel has a current price to earnings ratio of 26.13.
Ipca Laboratories (IPCALAB.NS) traded up 2.62 % and now trades at INR 1,980.8. Ipca Laboratories has a market capitalisation of INR 495.6 bn. Current price/earnings ratio for Ipca Laboratories is 37.17.